AZD1390 suppressed NF‐κB signaling pathway through restricting ubiquitylation and sumoylation of NEMO, which alleviated ischemic brain injury in experimental stroke and attenuated the activation of microglia and neuroinflammation. Here, IKBKG is linked to stroke disorder.